Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Local Therapy for Patients with Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma After Radical Treatment: a Prospective, Randomized Phase II Clinical Study

NCT03904927 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03904927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03904927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Local Therapy for Patients with Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma After Radical Treatment: a Prospective, Randomized Phase II Clinical Study
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2019
Completion date
September 15, 2024
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligorecurrent and oligometastatic esophageal squamous cell carcinoma